@article{ATM1187,
author = {Rossella Semeraro and Vincenzo Cardinale and Guido Carpino and Raffaele Gentile and Cristina Napoli and Rosanna Venere and Manuela Gatto and Roberto Brunelli and Eugenio Gaudio and Domenico Alvaro},
title = {The fetal liver as cell source for the regenerative medicine of liver and pancreas},
journal = {Annals of Translational Medicine},
volume = {1},
number = {2},
year = {2012},
keywords = {},
abstract = {Patients affected by liver diseases and diabetes mellitus are in need for sources of new cells to enable a better transition into clinic programs of cell therapy and regenerative medicine. In this setting, fetal liver is becoming the most promising and available source of cells. Fetal liver displays unique characteristics given the possibility to isolate cell populations with a wide spectrum of endodermal differentiation and, the co-existence of endodermal and mesenchymal-derived cells. Thus, the fetal liver is a unique and highly available cell source contemporarily candidate for the regenerative medicine of both liver and pancreas. The purpose of this review is to revise the recent literature on the different stem cells populations isolable from fetal liver and candidate to cell therapy of liver diseases and diabetes and to discuss advantages and limitation with respect to other cell sources.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/1187}
}